| Literature DB >> 35418364 |
Morgana Sluydts1, Marc Leblans2, Joost Js van Dinther2, Erwin Offeciers2, Robby Vanspauwen1, Floris L Wuyts1, Andrzej Zarowski2.
Abstract
BACKGROUND: Vestibular co-stimulation is a side effect of cochlear implant stimulation. The electrical currents delivered by the cochlear implant can spread toward the vestibular system and thus stimulate it. The aim of the study is to evaluate whether it is feasible to functionally restore the balance by modifying the vestibular co-stimulation.Entities:
Mesh:
Year: 2022 PMID: 35418364 PMCID: PMC9450210 DOI: 10.5152/iao.2022.21431
Source DB: PubMed Journal: J Int Adv Otol ISSN: 1308-7649 Impact factor: 1.316
Patient Demographics
| Subject 1 | Subject 2 | Subject 3 | Subject 4 | |||||
| Age at implantation (years) | 70 | 37 | 70 | 69 | ||||
| Age at time of the study (years) | 71 | 40 | 72 | 69* | ||||
| PTA (dB HL) | Right | Left | Right | Left | Right | Left | Right | Left |
| 65 | deaf | 93 | 92 | 85 | 85 | 68 | 73 | |
| Implant side | Left | Right | Right | Right | ||||
| Implant type | CI532 | CI512 | CI512 | CI532 | ||||
| Contralateral ear | Hearing aid | Hearing aid | Hearing aid | Unaided | ||||
| Diagnosis | Chronic middle ear disorders (progressive, permanent hearing loss) | Idiopathic SNHL with onset at 4 years old (unidentified hereditary component) | Idiopathic SNHL (probably due to streptomycin treatment during childhood) | Iatrogenic SNHL (streptomycin treatment during childhood) | ||||
SNHL, sensorineural hearing loss; CI, cochlear implant; PTA, pure tone audiometry (average of hearing thresholds at 500 Hz, 1000 Hz, and 2000 Hz) before implantation; dB HL, decibel hearing level.
*Six months after initial cochlear implant activation.
Semicircular Canal Function After Cochlear Implantation
| Implanted Ear | Unimplanted Ear | Caloric Test | ||||
| SHAT: Gain | vHIT: Gain | SHAT: Gain | vHIT: Gain | Caloric Sum (°/s) | Unilateral Weakness (%) | |
| S1 | 0.38 | 1.17 | 0.64 | 1.06 | Blind sac closure | Blind sac closure |
| S2 | 0.28 | 0.73 | 0.19 | 0.98 | 52°/s | 6% contralateral |
| S3 | 0.55 | 0.77 | 0.64 | 0.95 | 140°/s | 8% ipsilateral |
| S4 | 0.40 | 0.72 | 0.36 | 0.81 | 57°/s | 17% contralateral |
S, subject; ipsilateral/contralateral, ipsi- or contralateral with regard to the implanted ear; SHAT, sinusoidal harmonic acceleration test; vHIT, video head impulse test.
Otolith Function After Cochlear Implantation
| Implanted Ear | Unimplanted Ear | |||||
| cVEMP | oVEMP | cVEMP | oVEMP | |||
| Threshold (dB SPL) | Corrected Amplitude* | Amplitude (µV) | Threshold (dB SPL) | Corrected Amplitude* | Amplitude (µV) | |
| S1 | Absent | Absent | Absent | 130 | 1.0 | Absent |
| S2 | 115 | 1.2 | 21.0 | 120 | 1.7 | 17.3 |
| S3 | Absent | Absent | 14.8 | Absent | Absent | 13.3 |
| S4 | 135 | 0.4 | 9.7 | 125 | 1.4 | 5.7 |
S, subject; c/oVEMP, cervical/ocular vestibular-evoked myogenic potential; dB SPL, decibel sound pressure level.
*Measured at the highest level of stimulation.
Figure 1.The upper waveform represents a pulse train of biphasic pulses that were presented in bursts. The lower waveform is the amplitude-modulated biphasic pulse train.
Individual Stimulation Parameters: Biphasic Pulses Presented as Bursts
| Subject 1 | ||||||
| Intra-Burst Pulse Rate (pps) |
| Electrode Contact | Reference Electrode | Current Level | Current (µA) | Np/Burst |
| 4673 | 100 | E3 | MP1 + MP2 | 150 | 263 | 1 |
| 4673 | 20 | E3 | MP1 + MP2 | 170 | 377 | 1 |
| 4673 | 300 | E3 | MP1 + MP2 | 130 | 183 | 1 |
| 4673 | 10 | E3 | MP1 + MP2 | 175 | 413 | 1 |
| 4673 | 300 | E3 | MP1 + MP2 | 130 | 183 | 2 |
| 4673 | 100 | E3 | MP1 + MP2 | 120 | 153 | 4 |
| 2336 | 300 | E3 | MP1 + MP2 | 125 | 167 | 4 |
| 1558 | 100 | E3 | MP1 + MP2 | 140 | 219 | 8 |
| 4673 | 300 | E3 | MP1 + MP2 | 120 | 153 | 8 |
| 4673 | 20 | E3 | MP1 + MP2 | 150 | 263 | 16 |
| 4673 | 100 | E3 | MP1 + MP2 | 120 | 153 | 24 |
| 1168 | 20 | E3 | MP1 + MP2 | 145 | 240 | 24 |
| 4673 | 10 | E3 | MP1 + MP2 | 140 | 219 | 48 |
| 4673 | 20 | E3 | MP1 + MP2 | 130 | 183 | 96 |
| 4673 | 10 | E12 | MP1 + MP2 | 165 | 345 | 1 |
| 4673 | 10 | E22 | MP1 + MP2 | 140 | 219 | 1 |
| Subject 2 (First Visit) | ||||||
| Intra-Burst Pulse Rate (pps) |
| Electrode Contact | Reference Electrode | Current Level | Current (µA) | Np/burst |
| 4673 | 2 | E3 | MP1 + MP2 | 95 | 97 | 584 |
| 4673 | 2 | E3 | MP1 + MP2 | 100 | 107 | 292 |
| 4673 | 2 | E3 | MP1 + MP2 | 135 | 200 | 1 |
| Subject 3 | ||||||
| Intra-Burst Pulse Rate (pps) | fburst (Hz) | Electrode Contact | Reference Electrode | Current Level | Current (µA) | Np/Burst |
| 4673 | 2 | E3 | MP1 + MP2 | 120 | 153 | 1 |
| 4673 | 400 | E3 | MP1 + MP2 | 140 | 219 | 1 |
| 4673 | 100 | E3 | MP1 + MP2 | 145 | 240 | 1 |
| 4673 | 2 | E3 | MP1 + MP2 | 110 | 128 | 584 |
| 4673 | 400 | E3 | MP1 + MP2 | 130 | 183 | 3 |
| 4673 | 100 | E3 | MP1 + MP2 | 120 | 153 | 12 |
| 4673 | 100 | E3 | MP1 + MP2 | 125 | 167 | 12 |
| 4673 | 200 | E3 | MP1 + MP2 | 130 | 183 | 6 |
| 4673 | 10 | E3 | MP1 + MP2 | 130 | 183 | 117 |
| 4673 | 400 | E3 | MP1 + MP2 | 140 | 219 | 3 |
| Subject 4 | ||||||
| Intra-Burst Pulse Rate (pps) |
| Electrode Contact | Reference Electrode | Current Level | Current (µA) | Np/Burst |
| 4673 | 2 | E3 | MP1 + MP2 | 160 | 315 | 1 |
| 4673 | 2 | E3 | MP1 + MP2 | 160 | 315 | 1 |
| 4673 | 400 | E3 | MP1 + MP2 | 130 | 183 | 1 |
| 4673 | 100 | E3 | MP1 + MP2 | 140 | 219 | 1 |
| 4673 | 2 | E3 | MP1 + MP2 | 110 | 128 | 584 |
| 4673 | 400 | E3 | MP1 + MP2 | 125 | 167 | 3 |
| 4673 | 100 | E3 | MP1 + MP2 | 115 | 140 | 12 |
pps, pulses per second; f burst (Hz), burst frequency (Hertz); E3/12/22, basal/middle/apical electrode contact; MP1, ball reference electrode; MP2, fixed location on the implant; Np/burst, number of biphasic pulses in 1 burst.
Individual Stimulation Parameters: Amplitude-Modulated Pulse Train
| Subject 2 (First Visit) | |||||
| Pulse Rate (pps) | Modulation Frequency (Hz) | Electrode Contact | Reference Electrode | Current Level | Current (µA) |
| 4673 | 2 | E3 | MP1 + MP2 | 105 | 117 |
| 4673 | 400 | E3 | MP1 + MP2 | 110 | 128 |
| 4673 | 100 | E3 | MP1 + MP2 | 105 | 117 |
| 4673 | 20 | E3 | MP1 + MP2 | 105 | 117 |
| 4673 | 10 | E3 | MP1 + MP2 | 105 | 117 |
| 4673 | 2 | E3 | MP1 + MP2 | 105 | 117 |
| 4673 | 2 | E3 | MP1 + MP2 | 105 | 117 |
| 2336 | 2 | E3 | MP1 + MP2 | 105 | 117 |
| 1168 | 2 | E3 | MP1 + MP2 | 115 | 140 |
| 4673 | 2 | E12 | MP1 + MP2 | 115 | 140 |
| 4673 | 2 | E22 | MP1 + MP2 | 90 | 89 |
| 2336 | 2 | E22 | MP1 + MP2 | 90 | 89 |
| Subject 2 (Second Visit) | |||||
| Pulse Rate (pps) | Modulation Frequency (Hz) | Electrode Contact | Reference Electrode | Current Level | Current (µA) |
| 4673 | 20 | E3 | MP1 + MP2 | 105 | 117 |
| 4673 | 400 | E3 | MP1 + MP2 | 100 | 128 |
| 4673 | 2 | E3 | MP1 + MP2 | 105 | 117 |
| 4673 | 1 | E3 | MP1 + MP2 | 105 | 117 |
| 4673 | 5 | E3 | MP1 + MP2 | 105 | 117 |
| 4673 | 2 | E12 | MP1 + MP2 | 110 | 117 |
| 4673 | 2 | E22 | MP1 + MP2 | 100 | 117 |
| 4673 | 1 | E22 | MP1 + MP2 | 105 | 117 |
| 4673 | 2 | E22 | MP1 | 105 | 117 |
| 4673 | 2 | E22 | MP2 | 110 | 117 |
| 4673 | 1 | E3 | MP2 | 105 | 117 |
| Subject 3 | |||||
| Pulse Rate (pps) | Modulation Frequency (Hz) | Electrode Contact | Reference Electrode | Current Level | Current (µA) |
| 4673 | 2 | E3 | MP1 + MP2 | 90 | 89 |
| 4673 | 400 | E3 | MP1 + MP2 | 130 | 183 |
| 4673 | 100 | E3 | MP1 + MP2 | 115 | 140 |
| 4673 | 200 | E3 | MP1 + MP2 | 130 | 183 |
| 4673 | 10 | E3 | MP1 + MP2 | 125 | 167 |
| Subject 4 | |||||
| Pulse Rate (pps) | Modulation Frequency (Hz) | Electrode Contact | Reference Electrode | Current Level | Current (µA) |
| 4673 | 2 | E3 | MP1 + MP2 | 110 | 128 |
| 4673 | 400 | E3 | MP1 + MP2 | 120 | 153 |
| 4673 | 100 | E3 | MP1 + MP2 | 120 | 153 |
| 4673 | 2 | E22 | MP1 + MP2 | 115 | 140 |
| 4673 | 400 | E22 | MP1 + MP2 | 120 | 153 |
| 4673 | 100 | E22 | MP1 + MP2 | 115 | 140 |
| 4673 | 2 | E3 | MP1 | 125 | 167 |
| 4673 | 100 | E3 | MP1 | 115 | 140 |
| 4673 | 10 | E3 | MP1 | 115 | 140 |
pps, pulses per second; MP1, ball reference electrode; MP2, fixed location on the implant; E3/12/22, basal/middle/apical electrode contact.